<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24346898</article-id>
      <article-id pub-id-type="pmc">3876000</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20132449</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Cutaneous leiomyomatosis in a mother and daughter<xref ref-type="fn" rid="fn01">*</xref>
</article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>Leiomiomatose cut&#xE2;nea em m&#xE3;e e filha</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Lencastre</surname>
            <given-names>Andr&#xE9;</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cabete</surname>
            <given-names>Joana</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gon&#xE7;alves</surname>
            <given-names>Rui</given-names>
          </name>
          <xref ref-type="aff" rid="aff03">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jo&#xE3;o</surname>
            <given-names>Alexandre</given-names>
          </name>
          <xref ref-type="aff" rid="aff04">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fidalgo</surname>
            <given-names>Ana</given-names>
          </name>
          <xref ref-type="aff" rid="aff04">4</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label> Degree in Medicine - Resident physician at the Dermatology/Venereology
Department, Hospital de Santo Ant&#xF3;nio dos Capuchos - Centro Hospitalar de Lisboa
Central, EPE - Lisbon, Portugal.</aff>
      <aff id="aff02"><label>2</label> Integrated Masters Degree in Medicine - Resident physician at the
Dermatology/Venereology Department, Hospital de Santo Ant&#xF3;nio dos Capuchos - Centro
Hospitalar de Lisboa Central, EPE - Lisbon, Portugal.</aff>
      <aff id="aff03"><label>3</label> Degree in Medicine - Geneticist, Hospital de Dona Estef&#xE2;nea, Centro
Hospitalar de Lisboa Central, EPE - Lisbon, Portugal.</aff>
      <aff id="aff04"><label>4</label> Degree in Medicine - Collaborating Assistant MD in
Dermatology/Venereology in Department, Hospital de Santo Ant&#xF3;nio dos Capuchos, Centro
Hospitalar de Lisboa Central, EPE - Lisbon, Portugal.</aff>
      <author-notes>
        <corresp id="c01"><bold>Mailing address:</bold> Andr&#xE9; Lencastre, Hospital de Santo Ant&#xF3;nio dos
Capuchos, Alameda de Santo Ant&#xF3;nio dos Capuchos, 1169-050 - Lisbon, Portugal. E-mail:
<email>lencastre.derm@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Nov-Dec</season>
        <year>2013</year>
      </pub-date>
      <volume>88</volume>
      <issue>6 Suppl 1</issue>
      <fpage>124</fpage>
      <lpage>127</lpage>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>1</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>2</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2013 by Anais Brasileiros de Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>A 34-year-old woman with no known medical history was evaluated for multiple painful
brown nodules and papules on the anterior aspect of the trunk. She mentioned a
history of similar cutaneous findings on her mother. Biopsies of three lesions
revealed piloleiomyomata. Renal and adrenal ultrasound revealed an isolated simple
cortical cyst, and pelvic and endovaginal ultrasound revealed two uterine myomata.
The clinical diagnosis of hereditary leiomyomatosis and renal cell cancer was
corroborated by the identification of a heterozygous variant on exon 5 of the
fumarate hydratase gene (c.578C&gt;T p.T193I). Identification of the tumor
piloleiomyoma should alert the dermatologist to this rare genodermatosis, which is
associated with an increased risk of renal cell tumors, demanding multidisciplinary
follow-up, and personal and family counseling.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <p>Uma mulher de 34 anos sem antecedentes patol&#xF3;gicos conhecidos foi avaliada por
apresentar m&#xFA;ltiplos n&#xF3;dulos e p&#xE1;pulas castanhos, dolorosos, na face anterior do
tronco. Referia hist&#xF3;ria de achados cut&#xE2;neos semelhantes na sua m&#xE3;e. As bi&#xF3;psias de
tr&#xEA;s les&#xF5;es revelaram piloleiomiomas. As ecografias renal e suprarenal identificaram
apenas cisto renal cortical simples, e as ecografias endovaginal e p&#xE9;lvica, dois
miomas uterinos. O diagn&#xF3;stico cl&#xED;nico de leiomiomatose heredi&#xE1;ria e c&#xE2;ncer de
c&#xE9;lulas renais foi corroborado pela identifica&#xE7;&#xE3;o de variante heterozigota no exon 5
do gene da Fumarato hidratase (c.578C&gt;T p.T193I). O piloleimomioma &#xE9; um tumor cuja
identifica&#xE7;&#xE3;o deve alertar o dermatologista para esta rara genodermatose, associada a
um risco aumentado de tumores de c&#xE9;lulas renais, exigindo seguimento multidisciplinar
e aconselhamento pessoal e familiar.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>Carcinoma, renal cell</kwd>
        <kwd>Fumarate hydratase</kwd>
        <kwd>Leiomyoma</kwd>
        <kwd>Leiomyomatosis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Hereditary leiomyomatosis and renal cell cancer (HLRCC) is thought to be a rare,
autossomal dominant cancer syndrome of incomplete penetrance, caused by mutations of the
fumarate hydratase gene (<italic>FH</italic>) located on the 1q42.3-q43
region.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r02">2</xref></sup>
</p>
      <p>Several synonyms for HLRCC exist such as: multiple cutaneous and uterine leiomyomas 1
with or without renal cell cancer (MCUL1), and Reed's syndrome (cutaneous and uterine
leiomyomatosis).<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r03">3</xref></sup>
</p>
      <p>HLRCC variably predisposes to: <bold>1)</bold> cutaneous leiomyomatosis; <bold>2)</bold>
uterine leiomyomatosis (rarely with uterine leiomyosarcoma); and <bold>3)</bold> an
elevated risk of malignant renal tumors.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>Patient 1, a 34-year- old woman with no previously known diseases, was evaluated for a
long course of multiple papules and small nodules of brownish pink colour on the
anterior aspect of the upper body, painful either spontaneously or on exposure to cold
environments (<xref ref-type="fig" rid="f01">Figure 1</xref>). In the past she had two
lesions excised, albeit non-cognizant of their histological examination.</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>
<bold>Patient 1:</bold> Several brownish pink lesions on this patient&#x2019;s chest.
Note recurrence of two lesions adjacent to scars belonging to past excision of
lesions</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0124-g01"/>
      </fig>
      <p>She denied any similar lesions on her immediate family, except for her mother who was
also observed (<xref ref-type="fig" rid="f02">Figure 2</xref>). The 61-year-old mother
had similar lesions on her trunk and upper limbs and reported a total histerectomy for
symptomatic uterine myomatosis at age 38. They both recalled a history of uterine
myomatosis on the maternal grandmother. </p>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>
<bold>Patient 2:</bold> Several lesions on the dorsum of the mother of the
patient</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0124-g02"/>
      </fig>
      <p>Dermatoscopically, the lesions had a thin brownish pink pigment network (<xref ref-type="fig" rid="f03">Figure 3</xref>). Renal and adrenal gland ultrasound
identified a simple cortical renal cyst with 20 mm diameter, and pelvic and endovaginal
ultrasounds two uterine myomas with 10 and 6 mm in patient 1. Cutaneous biopsies of
three lesions from patient 1 and two from the mother revealed Piloleiomyomata (<xref ref-type="fig" rid="f04">Figure 4</xref> and <xref ref-type="fig" rid="f05">5</xref>). </p>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>
<bold>Patient 1:</bold> Brownish pink reticular pattern, with no other local
features except follicular ostia (image taken with Sony Cybershot<sup>&#xAE;</sup>
DSC-T77 digital camera and Dermlite<sup>&#xAE;</sup> II ProHr handheld dermoscope,
3Gen, LLC; original magnification &#xD7; 10)</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0124-g03"/>
      </fig>
      <fig id="f04" orientation="portrait" position="float">
        <label>FIGURE 4</label>
        <caption>
          <p>
<bold>Patient 1:</bold> Non encapsulated dermal tumor, with Grenz zone and
consisting of interlaced fibers of smooth muscle cells (H&amp;E &#xD7; 40)</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0124-g04"/>
      </fig>
      <fig id="f05" orientation="portrait" position="float">
        <label>FIGURE 5</label>
        <caption>
          <p>
<bold>Patient 1:</bold> Interlaced fibers of smooth muscle cells, with abundant
eosinophilic cytoplasm and elongated nuclei with blunt ends (H&amp;E &#xD7; 100)</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0124-g05"/>
      </fig>
      <p>A clinical diagnosis of HLRCC was made, corroborated by the identification of a
heterozygous variant on exon 5 of the Fumarate Hydratase gene (c.578C&gt;T p.T193I). </p>
      <p>The patient decided to excise the symptomatic lesions. </p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Although cases compatible with HLRCC already existed, the term Reed's Syndrome appeared
after Reed <italic>et al</italic> recognized tumoral predisposition in a family
afflicted by multiple uterine (UL) and cutaneous leiomyomas (CL).<sup><xref ref-type="bibr" rid="r01">1</xref></sup>
</p>
      <p>Multiple heterozygous mutations of the <italic>FH</italic> gene were later identified,
however with unknown implications in the generation of the multiple different phenotypes
of this syndrome.<sup><xref ref-type="bibr" rid="r04">4</xref></sup> In leiomyomatosis
individuals, the presumed tumor suppressor activity of the fumarate hydratase is
reduced.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r02">2</xref>,<xref ref-type="bibr" rid="r03">3</xref></sup>
</p>
      <p>The most prominent phenotypical characteristic of HLRCC is the appearance of
piloleiomyomas, with presumable origin in the arrector pili muscle. The number and size
of these tumors can vary considerably, giving rise to cutaneous settings that vary from
those that are practically unnoticeable to others that are severe and
extensive.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r03">3</xref></sup> The skin-colored, red or brown papules or nodules occur
in groups, scattered or both, on the limbs, trunk or face. Typically they cause pain on
palpation or at low temperatures. There is a low risk for skin
leiomyosarcomas.<sup><xref ref-type="bibr" rid="r03">3</xref></sup>
</p>
      <p>Dermoscopically, CLs have not been extensively described in the literature. Judging by
what has been published, the findings are unspecific, varying between structureless
homogeneous areas and a thin reticular pattern.<sup><xref ref-type="bibr" rid="r05">5</xref>,<xref ref-type="bibr" rid="r06">6</xref></sup>
</p>
      <p>The differential diagnosis should include: <bold>1) </bold>from a clinical point of
view, angiolipoma, glomus tumor and neurofibroma; and <bold>2) </bold>histologically,
smooth muscle hamartoma, dermatomyofibroma and dermatofibroma.<sup><xref ref-type="bibr" rid="r07">7</xref></sup>
</p>
      <p>ULs derived from the uterine smooth muscle cells are common benign tumors even in
healthy women. In HLRCC, they are more frequent (79-100% of cases), larger (up to 10
cm), more numerous (from 1 to 20), and appear at an earlier age (average of 30 versus 40
years in sporadic cases).<sup><xref ref-type="bibr" rid="r01">1</xref></sup> Apart from
menstrual irregularity or associated pain, a growing number of infertility cases have
been reported. The association with uterine leiomyosarcoma has been described as very
rare.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r08">8</xref></sup>
</p>
      <p>Although only 20-25% of patients apparently develop renal cell cancer (RCC), we prefer
the term HLRCC in order to highlight the importance of this association.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r03">3</xref></sup>
It is noteworthy that the majority of the RCC in these patients is exceptionally
aggressive, with early metastasis even when smaller than 1 cm.<sup><xref ref-type="bibr" rid="r01">1</xref></sup> Papillary RCC type 2 is the most frequent subtype,
followed by collecting duct RCC. When present, RCC is typically solitary and
unilateral.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r03">3</xref>,<xref ref-type="bibr" rid="r08">8</xref></sup> Renal cysts are
also more prevalent, in 36% patients <italic>versus</italic> 4.6% - 8.3% of the general
population.<sup><xref ref-type="bibr" rid="r01">1</xref></sup>
</p>
      <p>Although consensual criteria are lacking, according to those proposed by Smit <italic>et
al.</italic>, our patient met one major criterion (cutaneous leiomyomatosis) and one
minor criterion (first-degree relative treated surgically for UL, under age
40).<sup><xref ref-type="bibr" rid="r09">9</xref></sup> We also point to the
presence of multiple small leiomyomata and a cortical renal cyst on our patient. </p>
      <p>When the clinical and histopathological setting is suggestive, direct gene sequencing of
the <italic>FH</italic> codifying region should be made. </p>
      <p>Piloleiomyomata rarely demand treatment except for cosmetic purposes or for pain relief,
which in most cases is tolerable. In isolated tumors surgery is frequently resorted to.
For pain relief in multiple lesions, isolated or combination therapy with nitroglycerin,
adrenergic receptor blockers, analgesics, antidepressants, cryotherapy or CO<sub>2
</sub>laser may be used.<sup><xref ref-type="bibr" rid="r03">3</xref></sup>
</p>
      <p>In the follow-up and treatment of UL, the same gynecologic recommendations available for
the general population apply. Signs that suggest malignant transformation may be
screened for in gynecology.<sup><xref ref-type="bibr" rid="r03">3</xref></sup>
</p>
      <p>Currently there are no published guidelines for the screening of RCC in HLRCC, although
the main therapeutic focus of this disease should be its early detection. When a
<italic>FH</italic> germline mutation is identified, the patient and relatives should
be subjected to adapted screening programs. Computerized tomography (CT) at age 18 seems
to us to be a reasonable course of action, followed by ultrasound, or either CT or
magnetic resonance for suspicious lesions. In the first case, the surveillance interval
can be annual or every 2 years. Even though RCC is rare during childhood, this
possibility should be considered in families with a history of RCC at a young age, with
the screening test adapted to the child's age.<sup><xref ref-type="bibr" rid="r10">10</xref></sup>
</p>
      <p>Dermatological evaluation of patients with HLRCC is mandatory. The histological
confirmation of cutaneous tumors selected by their typical clinical appearance make the
diagnosis easier, potentially leading to prompt cancer detection in affected patients
and their families.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="fn01" fn-type="other">
        <label>*</label>
        <p>Work performed at the Dermatology Department, Santo Ant&#xF3;nio dos Capuchos Hospital -
Centro Hospitalar de Lisboa Central, EPE - Lisbon, Portugal.</p>
      </fn>
      <fn id="fn02" fn-type="conflict">
        <p>Conflict of interest: None</p>
      </fn>
      <fn id="fn03" fn-type="financial-disclosure">
        <p>Financial funding: None</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lehtonen</surname>
              <given-names>HJ</given-names>
            </name>
          </person-group>
          <article-title>Hereditary leiomyomatosis and renal cell cancer: update on clinical
and molecular characteristics</article-title>
          <source>Fam Cancer</source>
          <year>2011</year>
          <volume>10</volume>
          <fpage>397</fpage>
          <lpage>411</lpage>
          <pub-id pub-id-type="pmid">21404119</pub-id>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alam</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Bevan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Churchman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Barclay</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Barker</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Jaeger</surname>
              <given-names>EE</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Localization of a Gene (MCUL1) for Multiple Cutaneous Leiomyomata and
Uterine Fibroids to Chromossome 1q42.3-q43</article-title>
          <source>Am J Hum Genet</source>
          <year>2001</year>
          <volume>68</volume>
          <fpage>1264</fpage>
          <lpage>1269</lpage>
          <pub-id pub-id-type="pmid">11283798</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Badeloe</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Frank</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Clinical and molecular genetic aspects of hereditary multiple
cutaneous leiomyomatosis</article-title>
          <source>Eur J Dermatol</source>
          <year>2009</year>
          <volume>19</volume>
          <fpage>545</fpage>
          <lpage>551</lpage>
          <pub-id pub-id-type="pmid">19939761</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tomlinson</surname>
              <given-names>IP</given-names>
            </name>
            <name>
              <surname>Alam</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Rowan</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Barclay</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Jaeger</surname>
              <given-names>EE</given-names>
            </name>
            <name>
              <surname>Kelsell</surname>
              <given-names>D</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Germline mutations in FH predispose to dominantly inherited uterine
fibroids, skin leiomyomata and papillary renal cell cancer</article-title>
          <source>Nat Genet</source>
          <year>2002</year>
          <volume>30</volume>
          <fpage>406</fpage>
          <lpage>410</lpage>
          <pub-id pub-id-type="pmid">11865300</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paschoal</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Rezze</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Dermoscopic findings in a patient with multiple
pioleiomyomas</article-title>
          <source>Dermatol Pract Concept</source>
          <year>2012</year>
          <volume>2</volume>
          <fpage>27</fpage>
          <lpage>29</lpage>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>GW</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Ko</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>BS</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Giant piloleiomyoma of the forehead</article-title>
          <source>Ann Dermatol</source>
          <year>2011</year>
          <volume>23</volume>
          <fpage>S144</fpage>
          <lpage>S146</lpage>
          <pub-id pub-id-type="pmid">22148036</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Suzuki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Cavalin</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Werner</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Brenner</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">Caso para diagn&#xF3;stico. Piloleiomioma
m&#xFA;ltiplo</article-title>
          <source>An Bras Dermatol</source>
          <year>2007</year>
          <volume>82</volume>
          <fpage>190</fpage>
          <lpage>192</lpage>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kiuru</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Launonen</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Hietala</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Aittom&#xE4;ki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Vierimaa</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Salovaara</surname>
              <given-names>R</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Familial cutaneous leiomyomatosis is a two-hit condition associated
with renal cell cancer of characteristic histopathology</article-title>
          <source>Am J Pathol</source>
          <year>2001</year>
          <volume>159</volume>
          <fpage>825</fpage>
          <lpage>829</lpage>
          <pub-id pub-id-type="pmid">11549574</pub-id>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smit</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Mensenkamp</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Badeloe</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Breuning</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Simon</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>van Spaendonck</surname>
              <given-names>KY</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Hereditary leiomyomatosis and renal cell cancer in families referred
for fumarate hydratase germline mutation analysis</article-title>
          <source>Clin Genet</source>
          <year>2011</year>
          <volume>79</volume>
          <lpage>49</lpage>
          <fpage>59</fpage>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Spaendonck-Zwarts</surname>
              <given-names>KY</given-names>
            </name>
            <name>
              <surname>Badeloe</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Oosting</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Hovenga</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Semmelink</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>van Moorselaar</surname>
              <given-names>RJ</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Hereditary leiomyomatosis and renal cell cancer presenting as
metastatic kidney cancer at 18 years of ageimplications for
surveillance</article-title>
          <source>Fam Cancer</source>
          <year>2012</year>
          <volume>11</volume>
          <fpage>123</fpage>
          <lpage>129</lpage>
          <pub-id pub-id-type="pmid">22086304</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
